Table: Jcr Pharmaceuticals - 9-MTH group results

JCR Pharmaceuticals

31/01/2023 07:00

Jan 31 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               26.70               40.27            45.00    
                   (-33.7 pct)        (+107.3 pct)      (-11.9 pct) 
  Operating            4.95               18.36            14.50    
                   (-73.0 pct)        (+364.4 pct)      (-27.3 pct) 
  Recurring            5.29               18.72            14.50    
                   (-71.7 pct)        (+362.8 pct)      (-29.3 pct) 
  Net                  3.57               12.92            10.30    
                   (-72.4 pct)        (+295.8 pct)      (-29.0 pct) 
  EPS               28.73 yen          104.45 yen        83.25 yen  
  EPS Diluted       28.61 yen          104.03 yen                   
  Ann Div                               22.00 yen        20.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               12.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T